Table 2. Demographics of glioblastoma at first or second recurrence: Toca 511 and Toca FC versus lomustine.
Treatment group
characteristics
Toca 511 and Toca FC
(n = 27)
n (%)
Lomustine
(n = 84)
n (%)
Sex
  Female4 (14.8)33 (39.3)
  Male23 (85.2)51 (60.7)
Age, years
  Median6154
  Range41–7118–75
Age, years
  <505 (18.5)27 (32.1)
  ≥5022 (81.5)57 (67.9)
KPS
  70–807 (25.9)41 (48.8)
  90–10020 (74.1)43 (51.2)
Time from diagnosis (months)
  Median11.611.5
  Range5.1–49.44.4–92.1
Recurrence
  First19 (70.4)65 (77.4)
  Second8 (29.6)19 (22.6)
Baseline steroid administration
  Yes23 (85.2)46 (54.8)
  No4 (14.8)38 (45.2)